PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

China flag China · Delayed Price · Currency is CNY
37.67
+0.78 (2.11%)
Mar 10, 2026, 2:25 PM CST
-4.00%
Market Cap 8.59B
Revenue (ttm) 1.98B
Net Income (ttm) 201.14M
Shares Out 232.97M
EPS (ttm) 1.00
PE Ratio 36.92
Forward PE 48.54
Dividend 0.28 (0.75%)
Ex-Dividend Date May 30, 2025
Volume 4,616,161
Average Volume 5,800,501
Open 36.50
Previous Close 36.89
Day's Range 36.50 - 37.90
52-Week Range 27.07 - 53.54
Beta 0.65
RSI 38.96
Earnings Date Apr 22, 2026

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, DNA encoded library technology, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small... [Read more]

Sector Healthcare
Founded 2006
Employees 2,455
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300725
Full Company Profile

Financial Performance

In 2024, SHE:300725's revenue was 1.69 billion, a decrease of -2.12% compared to the previous year's 1.73 billion. Earnings were 219.54 million, an increase of 11.24%.

Financial Statements

News

There is no news available yet.